{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:17:36Z","timestamp":1760955456989},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T00:00:00Z","timestamp":1424044800000},"content-version":"vor","delay-in-days":352,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","krcp-ksn.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Research and Clinical Practice"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.krcp.2013.11.004","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T15:30:26Z","timestamp":1391441426000},"page":"3-8","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of phosphate retention: The earlier the better?"],"prefix":"10.1016","volume":"33","author":[{"given":"Patrick","family":"Biggar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K.S.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.krcp.2013.11.004_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u2014 phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2013.11.004_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2215\/CJN.01831105","article-title":"Calcium-based phosphate binders are appropriate in chronic renal failure","volume":"1","author":"Friedman","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2215\/CJN.03850907","article-title":"Battleground: chronic kidney disorders mineral and bone disease \u2014 calcium obsession, vitamin D, and binder confusion","volume":"3","author":"Kovesdy","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2215\/CJN.05970809","article-title":"Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content","volume":"5","author":"Bushinsky","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Alberta Kidney Disease Network: Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.krcp.2013.11.004_bib6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.krcp.2013.11.004_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2013.11.004_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.krcp.2013.11.004_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","article-title":"Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers","volume":"71","author":"Brown","year":"1991","journal-title":"Physiol Rev"},{"key":"10.1016\/j.krcp.2013.11.004_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.krcp.2013.11.004_bib11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib12","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0977","article-title":"Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?","volume":"5","author":"Wetmore","year":"2009","journal-title":"Natl Clin Pract Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib14","doi-asserted-by":"crossref","unstructured":"Cannata-And\u00eda J.B., Fern\u00e1ndez-Mart\u00edn J.L., Locatelli F., London G., Gorriz J.L., Floege J., Ketteler M., Ferreira A., Covic A., Rutkowski B., Memmos D., Bos W.J., Teplan V., Nagy J., Tielemans C., Verbeelen D., Goldsmith D., Kramar R., Martin P.Y., W\u00fcthrich R.P., Pavlovic D., Benedik M., S\u00e1nchez J.E., Mart\u00ednez-Camblor P., Naves-D\u00edaz M., Carrero J.J., Zoccali C.: Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int. 84:998\u20131008, 2013","DOI":"10.1038\/ki.2013.185"},{"key":"10.1016\/j.krcp.2013.11.004_bib15","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1073\/pnas.111154898","article-title":"FGF23, hypophosphatemia, and rickets: has phosphatonin been found?","volume":"98","author":"Strewler","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.krcp.2013.11.004_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relation to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.krcp.2013.11.004_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.krcp.2013.11.004_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.krcp.2013.11.004_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.krcp.2013.11.004_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0b013e328303e172","article-title":"Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion","volume":"17","author":"Galitzer","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.krcp.2013.11.004_bib21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","article-title":"Severely reduced production of klotho in human chronic renal failure kidney","volume":"280","author":"Koh","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.krcp.2013.11.004_bib24","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1074\/jbc.M312392200","article-title":"Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides","volume":"279","author":"Tohyama","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.krcp.2013.11.004_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2170\/jjphysiol.54.93","article-title":"Physiological regulation of renal sodium-dependent phosphate cotransporters","volume":"54","author":"Miyamoto","year":"2004","journal-title":"Jpn J Physiol"},{"key":"10.1016\/j.krcp.2013.11.004_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11560-012-0646-7","article-title":"Was gibt es neues in der CKD-MBD-Pathogenese?","volume":"8","author":"Seiler","year":"2013","journal-title":"Nephrologe"},{"key":"10.1016\/j.krcp.2013.11.004_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.mad.2010.02.008","article-title":"A potential link between phosphate and aging\u2014lessons from Klotho-deficient mice","volume":"131","author":"Kuro-o","year":"2010","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.krcp.2013.11.004_bib28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor-23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.krcp.2013.11.004_bib29","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/ndt\/gfr645","article-title":"Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism","volume":"27","author":"Komaba","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2013.11.004_bib31","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.krcp.2013.11.004_bib32","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1172\/JCI105877","article-title":"Control of phosphate excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.krcp.2013.11.004_bib33","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib34","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/ndt\/gfs259","article-title":"FGF-23: the rise of a novel cardiovascular risk marker in CKD","volume":"27","author":"Heine","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib35","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.krcp.2013.11.004_bib36","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gft065","article-title":"Fibroblast growth factor-23: what we know, what we don\u2019t know, and what we need to know","volume":"28","author":"Kovesdy","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ndt\/gfs557","article-title":"FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease","volume":"28","author":"Ketteler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib38","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib39","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib40","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease","volume":"161","author":"Taylor","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.krcp.2013.11.004_bib42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bone.2012.02.634","article-title":"Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis","volume":"50","author":"Nakano","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.krcp.2013.11.004_bib43","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.krcp.2013.11.004_bib44","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.krcp.2013.11.004_bib45","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib46","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.2012060569","article-title":"Phosphate binders in CKD: bad news or good news?","volume":"23","author":"Dr\u00fceke","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.krcp.2013.11.004_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5414\/CN107257","article-title":"Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study","volume":"78","author":"Toida","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.krcp.2013.11.004_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.krcp.2013.11.004_bib51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","article-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","volume":"65","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.krcp.2013.11.004_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1744-9987.2005.00292.x","article-title":"Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23","volume":"9","author":"Miyamoto","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.krcp.2013.11.004_bib53","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib54","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD","volume":"23","author":"Schiavi","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.krcp.2013.11.004_bib55","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.krcp.2013.11.004_bib56","doi-asserted-by":"crossref","unstructured":"Jamal S.A., Vandermeer B., Raggi P., Mendelssohn D.C., Chatterley T., Dorgan M., Lok C.E., Fitchett D., Tsuyuki R.T.: Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382:1268\u20131277, 2013","DOI":"10.1016\/S0140-6736(13)60897-1"}],"container-title":["Kidney Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913213001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211913213001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:18:05Z","timestamp":1565165885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211913213001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2211913213001149"],"URL":"https:\/\/doi.org\/10.1016\/j.krcp.2013.11.004","relation":{},"ISSN":["2211-9132"],"issn-type":[{"value":"2211-9132","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of phosphate retention: The earlier the better?","name":"articletitle","label":"Article Title"},{"value":"Kidney Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.krcp.2013.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Korea LLC.","name":"copyright","label":"Copyright"}]}}